Epigenetic reprograming in ATM-deficient pancreatic cancer: targeting EZH2-mediated oncogenic traits

被引：0
|
作者：
Roger, Elodie
Harle, Anna
Perkhofer, Lukas
Hessmann, Elisabeth
Kleger, Alexander
Gout, Johann
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-B088
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B088
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Activation of AKT induces EZH2-mediated 0 -catenin trimethylation in colorectal cancer
    Ghobashi, Ahmed H.
    Vuong, Truc T.
    Kimani, Jane W.
    Ladaika, Christopher A.
    Hollenhorst, Peter C.
    O'Hagan, Heather M.
    ISCIENCE, 2023, 26 (09)
  • [22] MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21
    Li Liu
    Feng Xu
    Chun-Kang Chang
    Qi He
    Ling-Yun Wu
    Zheng Zhang
    Xiao Li
    Cell Death & Disease, 2017, 8 : e3126 - e3126
  • [23] MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21
    Liu, Li
    Xu, Feng
    Chang, Chun-Kang
    He, Qi
    Wu, Ling-Yun
    Zhang, Zheng
    Li, Xiao
    CELL DEATH & DISEASE, 2017, 8 : e3126 - e3126
  • [24] P38α/JNK signaling restrains erythropoiesis by suppressing Ezh2-mediated epigenetic silencing of Bim
    Hu, Ping
    Nebreda, Angel R.
    Hanenberg, Helmut
    Kinnebrew, Garrett H.
    Ivan, Mircea
    Yoder, Mervin C.
    Filippi, Marie-Dominique
    Broxmeyer, Hal E.
    Kapur, Reuben
    NATURE COMMUNICATIONS, 2018, 9
  • [25] MYCN CONTRIBUTES TO THE MALIGNANT CHARACTERISTICS OF ERYTHROLEUKEMIA THROUGH EZH2-MEDIATED EPIGENETIC REPRESSION OF P21
    Xu, F.
    Chang, C. K.
    Li, X.
    He, Q.
    Wu, L. Y.
    LEUKEMIA RESEARCH, 2017, 55 : S92 - S94
  • [26] P38α/JNK Signaling Restrains Erythropoiesis By Suppressing Ezh2-Mediated Epigenetic Silencing of Bim
    Hu, Ping
    Nebreda, Angel
    Hanenberg, Helmut
    Kinnebrew, Garrett
    Ivan, Mircea
    Yoder, Mervin C.
    Filippi, Marie-Dominique
    Broxmeyer, Hal E.
    Kapur, Reuben
    BLOOD, 2018, 132
  • [27] Role of EZH2-mediated epigenetic modification on vascular smooth muscle in cardiovascular diseases: A mini-review
    Luo, Haiyan
    Li, Yao
    Song, Honghu
    Zhao, Kui
    Li, Wenlin
    Hong, Hailan
    Wang, Yun-Ting
    Qi, Luming
    Zhang, Yang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] O-GlcNAc and EZH2-mediated epigenetic regulation of gene expression during consolidation of fear memories
    Butler, Anderson A.
    Sanchez, Richard G.
    Jarome, Timothy J.
    Webb, William M.
    Lubin, Farah D.
    LEARNING & MEMORY, 2019, 26 (09) : 373 - 379
  • [29] An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage
    Kuser-Abali, Gamze
    Gong, Lu
    Yan, Jiawei
    Liu, Qingqing
    Zeng, Weiqi
    Williamson, Amanda
    Lim, Chuan Bian
    Molloy, Mary Ellen
    Little, John B.
    Huang, Lei
    Yuan, Zhi-Min
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (13) : 3452 - 3457
  • [30] Long non-coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2-mediated epigenetic modification
    Yu, Yi
    Zou, Yu-Feng
    Hong, Run-Qi
    Chen, Wen-Jie
    Chen, Liang
    Chen, Wen-Qi
    Wang, Hui-Peng
    Yu, Yuan
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2022, 38 (10): : 981 - 991
12345